No publications last week, but five (well, kind of) this week:

• Costs of In-House Genomic Profiling and Implications for Economic Evaluation: A Case Example of Non-Small Cell Lung Cancer (NSCLC) | link
• Multi-gene Assays: Effect on Chemotherapy Use, Toxicity and Cost in Estrogen Receptor-Positive Early Stage Breast Cancer | link
• Ending the Diagnostic Odyssey—Is Whole-Genome Sequencing the Answer? | link
• Economic Value of Exome Sequencing for Suspected Monogenic Disorders [letter] | link
• Response to Ferket Et Al [response to letter] | link

I’m happy to share any other publications from this week that I’ve missed – just let me know.